1Levin AS, Spitler LE, Stites DP, Fundenberg HH (1970) Wiscott Aldrich syndrome, a genetically determined cellular immunologic deficiency clinical and laboratory responses to therapy with transfer factor. Proc Natl Acad Sci USA 67: 821-8.

2Fudenberg HH, Pizza G (1993) Transfer factor 1993: new frontiers. Prog Drug Res 42: 309-400.

3Kirkpatrick CH, Burger DR, Lawrence HS (1983) Immunobiology of Transfer Factor. Academic Press, New York, USA.

4Lawrence HS (1955) The transfer in humans of delayed skin sensitivity to streptococcal M substance and to tuberculin with disrupted leucocytes. J Clin Investig 34: 219-30.

5Wilson GB, Poindexter C, Fort JF, Ludden KD (1988) De novo initiation of specific cell-mediated immune responsiveness in chicken by transfer factor (specific immunity inducer) obtained from bovine colostrum and milk. Acta Virol 32: 6-18.

6Radosevich JK, Scott GH, Olson GB (1985) Delayed-type hypersensitivity responses induced by bovine colostral components. Am J Vet Res 46: 875-8.

7Wang JF, Park AJ, Rendini RN, Levis WR (2017) Lawrence transfer factor: Transference of specific immune memory by dialyzable leukocyte extract from a CF8+ T cell line. J Drugs Dermatol 16: 1198-206.

8Krishnaveni M (2013) A review on transfer factor an immune modulator. Drug Invent Today 5: 153-6.

9Vetvicka V, Holub M, Kovaru H, Siman P, Kovaru F (1988) Alpha-fetoprotein and phagocytosis in athymic nude mice. Immunol Lett 19: 95-88.

10Vetvicka V, Vetvickova J (2010) β1,3-Glucan: Silver bullet of hot air? Open Glycoscience 3: 1-6.

11 Zajicova A, Javorkova E, Trosan P, Chudickova M, Krulova M, et al. (2014) A low-molecular-weight dialyzable leukocyte extract selectively enhances development of CD4 (+)RORgamma(+) T cells and IL-17 production. Fol Biol (Praha) 60: 253-60.

12 Xu YP, Zou WM, Zhan XJ, Yang SH, Xie DZ, et al. (2006) Preparation and determination of immunological activities of anti-HBV egg yolk extraction. Cell Mol Immunol 3: 67-71.

13 Zhou J, Kong C, Yuan Z, Luo J, Ma RA, et al. (2013) Preparation, characterization, and determination of immunological activities of transfer factor specific to human sperm antigen. Biomed Res Int 2013: 126923.

14Fabre RA, Perez TM, Aguilar LD, Rangel MJ, Estrada-Garcia I, et al. (2004) Transfer factors as immunoimmunotherapy and supplement of chemotherapy in experimental pulmonary tuberculosis. Clin Exp Immunol 136: 215-23.

15 Raise E, Guerra L, Viza D, Pizza G, De Vinci C, et al. (1996) Preliminary results in HIV-1-infected patients treated with transfer factor (TF) and zidovudine (ZDV). Biotherapy 9: 49-54.

16Miller LL, Spitler LE, Allen RE, Minor DR (1988)A randomized, double-blind, placebo-controlled trial of transfer factor as adjuvant therapy for malignant melanoma. Cancer 61: 1543-9.

17Pineda B, Estrada-Parra S, Pedraza-Medina B, Rodriguez-Ropon A, Perez R, et al. (2005) Interstitial transfer factor as adjuvant immunotherapy for experimental glioma. J Exp Clin Cancer Res 24: 575-83.

18 Kirkpatrick CH, Hamad AR, Morton LC (1995) Murine transfer factors: dose- response relationships and routes of administration. Cell Immunol 164: 203-6.

19 Vetvicka V, Fornusek L, Kopecek J, Kamínková J, Kaspárek L, et al. (1982) Phagocytosis of human blood leukocytes: A simple micromethod. Immunol Lett 5: 97-100.